Skip to main content
Livermore
Livermore
ZHEN

Journey Advisory Group, LLC

SEC CIK
0001840085
Latest filing
Aug 4, 2026

The latest 13F from Journey Advisory Group, LLC covers Q2 2026 (filed Aug 4, 2026): 282 long positions worth $1.31B. The top 10 holdings make up 28.4% of the portfolio, and the largest is PIMCO ETF Tr at 4.8%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
48
Est. +$73.0M
Added
111
Est. +$86.4M
Reduced
94
Est. −$95.2M
Sold out
8
Est. −$7.93M

Top 5 holdings

Share of this quarter's portfolio value

  1. PIMCO ETF Tr72201R585
    4.8%$63.4M
  2. Vanguard Ftse Developed Markets ETF921943858
    4.3%$56.8M
  3. AAPLApple Inc.
    3.2%$42.3MHistory
  4. iShares MSCI USA Momentum Factor ETF46432F396
    2.8%$37.3M
  5. MSFTMicrosoft Corp
    2.6%$33.5MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. iShares Tr464287515
    +$22.3MNew
  2. iShares MSCI USA Momentum Factor ETF46432F396
    +$16.1MAdded
  3. Invesco QQQ Trust Series I46090E103
    +$8.53MAdded
  4. iShares U.S. Medical Devices ETF464288810
    +$6.62MNew
  5. CLXClorox Co
    +$6.24MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. iShares Tr464287515
    +1.70 pp0.0% → 1.7%
  2. iShares MSCI USA Momentum Factor ETF46432F396
    +1.58 pp1.3% → 2.8%
  3. Invesco QQQ Trust Series I46090E103
    +0.70 pp0.4% → 1.1%
  4. iShares U.S. Medical Devices ETF464288810
    +0.51 pp0.0% → 0.5%
  5. CLXClorox Co
    +0.48 pp0.0% → 0.5%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. iShares Tr46436E718
    −$46.0MReduced
  2. Doubleline ETF Trust25861R105
    −$10.2MReduced
  3. Ssga Active ETF Tr78467V848
    −$9.74MReduced
  4. iShares Tr464288182
    −$5.29MReduced
  5. Exchange Listed FDS Tr30151E517
    −$4.44MReduced

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. iShares Tr46436E718
    −4.11 pp5.5% → 1.4%
  2. Doubleline ETF Trust25861R105
    −1.00 pp1.9% → 0.9%
  3. Ssga Active ETF Tr78467V848
    −0.95 pp1.8% → 0.8%
  4. JBSJBS N.V.
    −0.35 pp0.6% → 0.2%History
  5. iShares Tr464288182
    −0.35 pp0.5% → 0.2%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.31B
+$142.5M (+12.2%) vs. prior quarter
Positions
282
+40 vs. prior quarter
Top 10 concentration
28.4%
Top 10 as share of value
Turnover
8.3%
Q2 2026, one quarter
Average holding period
14.6 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.35B (Q3 2025)

Q1 2021: $285.9MQ2 2021: $314.2MQ3 2021: $308.6MQ4 2021: $362.0MQ1 2022: $394.9MQ2 2022: $435.4MQ3 2022: $391.9MQ4 2022: $402.0MQ1 2023: $632.7MQ2 2023: $668.9MQ3 2023: $669.6MQ4 2023: $735.3MQ1 2024: $811.4MQ2 2024: $836.7MQ3 2024: $835.2MQ4 2024: $834.6MQ1 2025: $1.22BQ2 2025: $1.29BQ3 2025: $1.35BQ4 2025: $1.19BQ1 2026: $1.17BQ2 2026: $1.31B
Q1 2021Q2 2026
13F filings of Journey Advisory Group, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 4, 2026282$1.31BPIMCO ETF TrVanguard Ftse Developed Markets ETFAAPLvs. Q1 2026SEC
Q1 2026May 5, 2026242$1.17BiShares TrPIMCO ETF TrVanguard Ftse Developed Markets ETFvs. Q4 2025SEC
Q4 2025Jan 27, 2026262$1.19BVanguard Ftse Developed Markets ETFiShares Core S&P Mid-Cap ETFMSFTvs. Q3 2025SEC
Q3 2025Nov 10, 2025266$1.35BRIOMSFTiShares Core S&P Mid-Cap ETFvs. Q2 2025SEC
Q2 2025Jul 30, 2025273$1.29BRIOMSFTiShares Core S&P Mid-Cap ETFvs. Q1 2025SEC
Q1 2025May 13, 2025271$1.22BRIOiShares Core S&P Mid-Cap ETFVanguard Total Bond Market ETFvs. Q4 2024SEC
Q4 2024Feb 4, 2025224$834.6MiShares Core S&P Mid-Cap ETFMSFTAAPLvs. Q3 2024SEC
Q3 2024Nov 12, 2024224$835.2MiShares Core S&P Mid-Cap ETFMSFTAAPLvs. Q2 2024SEC
Q2 2024Aug 2, 2024223$836.7MiShares Core S&P Mid-Cap ETFMSFTAAPLvs. Q1 2024SEC
Q1 2024May 9, 2024234$811.4MiShares Core S&P Mid-Cap ETFMSFTPGvs. Q4 2023SEC
Q4 2023Feb 14, 2024Amended214$735.3MiShares Core S&P Mid-Cap ETFAAPLMSFTvs. Q3 2023SEC
Q3 2023Nov 15, 2023212$669.6MiShares Core S&P Mid-Cap ETFAAPLMSFTvs. Q2 2023SEC
Q2 2023Aug 9, 2023225$668.9MAAPLMSFTiShares Core S&P Mid-Cap ETFvs. Q1 2023SEC
Q1 2023May 4, 2023231$632.7MAAPLMSFTPGvs. Q4 2022SEC
Q4 2022Feb 7, 2023216$402.0MPGAAPLMSFTvs. Q3 2022SEC
Q3 2022Nov 9, 2022235$391.9MAAPLMSFTPGvs. Q2 2022SEC
Q2 2022Aug 2, 2022242$435.4MAAPLMSFTPGvs. Q1 2022SEC
Q1 2022May 13, 2022217$394.9MAAPLPGMSFTvs. Q4 2021SEC
Q4 2021Feb 11, 2022208$362.0MAAPLPGMSFTvs. Q3 2021SEC
Q3 2021Nov 12, 2021196$308.6MAAPLPGMSFTvs. Q2 2021SEC
Q2 2021Aug 13, 2021199$314.2MAAPLPGMSFTvs. Q1 2021SEC
Q1 2021May 11, 2021194$285.9MAAPLPGiShares Core S&P Mid-Cap ETF–SEC